Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Purchase |
2025-03-17 5:09 pm |
FRACTYL HEALTH INC. | GUTS | SCHULMAN AMY W Director |
8,550 | $1.1654 | $9,964 | 8,550 (Direct) |
View |
| 2024-10-15 Purchase(A) |
2024-10-22 5:31 pm |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
| 2024-10-15 Purchase |
2024-10-15 6:00 pm |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
| 2024-06-25 Sale |
2024-06-27 4:04 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $240 | $2,040,000 | 11,186 (Direct) |
View |
| 2024-05-29 Sale |
2024-05-31 7:00 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
21,700 | $148.6 | $3,224,546 | 8,436 (Direct) |
View |
| 2021-12-13 Purchase |
2021-12-15 5:15 pm |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
3,700 | $10.91 | $40,367 | 3,196,040 (Indirect Direct) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:00 pm |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
250,000 | $16 | $4,000,000 | 2,739,990 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $0 | 11,186 (Direct) |
View |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $131.21 | 11,186 (Direct) |
View |
| 2024-10-15 Conversion(A) |
2024-10-22 5:31 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
Ownership(A) |
2024-10-22 5:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W Chee Brian 10% Owner |
0 | $0 | 909,090 (Indirect) |
View |
| 2024-10-15 Conversion |
2024-10-15 6:00 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
Ownership |
2024-10-15 5:32 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W 10% Owner |
0 | $0 | 909,090 (Indirect) |
View |
| 2024-06-25 Exercise |
2024-06-27 4:04 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $0 | 11,186 (Direct) |
View |
| 2024-06-25 Exercise |
2024-06-27 4:04 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $131.21 | 11,186 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A 2024-07-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $0 | 8,436 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $66.83 | 8,436 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:04 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 5:05 pm |
N/A 2034-01-31 |
Fractyl Health Inc. | GUTS | SCHULMAN AMY W Director |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2024-02-01 6:13 pm |
N/A 2028-08-29 |
Fractyl Health Inc. | GUTS | SCHULMAN AMY W Director |
0 | $0 | 140,783 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:46 pm |
N/A 2033-06-13 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
39,875 | $0 | 39,875 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:04 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 4:13 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
136 | $0 | 136 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:01 pm |
N/A 2032-06-14 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:06 pm |
2023-05-18 2032-05-17 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
5,153 | $0 | 5,153 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
136 | $0 | 136 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A 2028-03-04 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
24,130 | $0 | 3,229,480 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
10,091 | $2.02 | 3,229,480 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 5:15 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
14,039 | $4.59 | 3,229,480 (Direct) |
View |
| 2021-10-27 Option Award |
2021-10-29 4:07 pm |
2022-10-27 2031-10-26 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
1,814 | $0 | 1,814 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-19 4:21 pm |
2022-07-15 2031-07-14 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
4,032 | $0 | 4,032 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
10,500 | $0 | 10,500 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:00 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
5,411,716 | $0 | 2,739,990 (Indirect) |
View |
| 2020-10-29 Option Award |
2020-10-30 6:30 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
7,055 | $0 | 7,055 (Direct) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A N/A |
SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner |
0 | $0 | 2,975,780 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:50 pm |
2021-07-01 2030-07-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
4,581 | $0 | 4,581 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:15 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | SCHULMAN AMY W Director |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2020-06-08 7:29 pm |
N/A N/A |
Hudson Executive Investment Corp. | HEC | SCHULMAN AMY W Director |
0 | $0 | 25,000 (Direct) |
View |